Advertisement
Provider collaboration with local specialty pharmacies is associated with reduced delays in therapy and lower rates of direct-acting antiviral denial for patients with hepatitis C

Pharmacies Can Up Access to Direct-Acting Antivirals for Hep C

0
Collaboration with local specialty pharmacy linked to reduced delays in therapy, lower rates of denial
Vaccination for influenza for multiple seasons is twice as effective in preventing severe influenza -- compared with non-severe influenza -- in older patients admitted to hospital

Repeated Flu Vaccinations Help Prevent Severe Infection

0
Annual vaccination found to lessen flu severity, hospitalizations, and death among the elderly
Fluorouracil application can reduce the risk of surgery for squamous cell carcinoma for one year among patients with a history of keratinocyte carcinomas

Fluorouracil Tied to Reduced Surgery for Squamous Cell CA

0
Reduced risk of squamous cell carcinoma, but not basal cell carcinoma, for one year in at-risk veterans
Esketamine seems to be efficacious and safe for patients with treatment-resistant depression

Esketamine Safe, Effective for Treatment-Resistant Depression

0
Change in Montgomery-Åsberg Depression Rating Scale score superior for esketamine versus placebo
Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease

Immune-Related Adverse Events Up With Checkpoint Inhibitors

0
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy
For patients with chronic obstructive pulmonary disease

CVD Risk Up With β2-Agonist, Antimuscarinic Antagonist Start

0
New use of long-acting β2-agonists, antimuscarinic antagonists tied to higher CVD risk in first 30 days
Improvement in obstetrician-gynecologists' knowledge and prescribing practices regarding opioids is needed

Improvement Needed in Ob-Gyn Opioid Prescribing Practices

0
Respondents prescribed median of 26 pills/patient; amount prescribed varied widely by indication
Dasiglucagon is well tolerated and is associated with an early pharmacodynamic response similar to that of GlucaGen for severe hypoglycemia

Dasiglucagon Well Tolerated for Severe Hypoglycemia

0
Early pharmacodynamic response similar to that of GlucaGen, with longer lasting effects plasma glucose
For patients with acute severe ulcerative colitis

Predictors of Infliximab Response in Ulcerative Colitis Identified

0
Baseline Mayo Endoscopic Score, CRP/albumin ratio predict treatment response and risk for colectomy
Few modern

Few Immuno-Oncology Agents Reach ASCO Efficacy Thresholds

0
Durable survival, response rates rarely recognized as significant by current oncology value frameworks